Trends in interventional clinical trials: Biologics

INTERVENTIONAL STUDIES: BIOLOGICS
Results | Phases | Purpose | Endpoints | Funding | Design
Source: ClinicalTrials.gov
Data download date: December 26, 2016
Publication date: January 29, 2017
Analytical tool: IBM Watson
ARETE-ZOE, LLC: 1334 E Chandler Blvd 5A-19, 85048 Phoenix, AZ, USA | T:+1-480-409-0778 (24/7) | website: http://www.aretezoe.com/

DRUG STUDIES
STUDY RESULTS
All studies with completion date in the future marked as 2018
Studies with start date in 2017 and beyond removed

Study Results
Number of Studies by Results over Time (completion date)
Drugs
Biologics

Study Results
Breakdown of Study Results by Phase
Drugs
Biologics

DRUG STUDIES
STUDY PHASES

Study Phases
Number of Studies by Phase over Time (completion date)
Drugs
Biologics

DRUG STUDIES
STUDY ENDPOINTS

Study Endpoints
Number of Studies by Endpoint over Time (completion date)
Drugs
Biologics

Study Endpoints
Breakdown of Study Endpoints by Phase
Drugs
Biologics
Drugs

DRUG STUDIES
STUDY FUNDING

Study Funding
Number of studies by Funding over Time (completion date)
Biologics
Drugs

Study Funding
Breakdown of Study Funding by Phase
Biologics
Drugs

DRUG STUDIES
STUDY PURPOSE

Study Purpose
Number of Studies by Purpose over Time (completion date)
BiologicsDrugs

Study Purpose
Breakdown of Study Purpose by Phase
Biologics
Drugs

DRUG STUDIES
STUDY DESIGN: ALLOCATION

Study Design: Allocation
Number of Studies by Allocation over Time (completion date)
BiologicsDrugs

Study Design: Allocation
Breakdown of Study Design by Phase
Biologics
Drugs

DRUG STUDIES
STUDY DESIGN: ASSIGNMENT

Study Design: Assignment
Number of studies by Assignment over Time (completion date)
Biologics
Drugs

DRUG STUDIES
STUDY DESIGN: MASKING

Study Design: Masking
Number of studies by Masking over Time (completion date)
BiologicsDrugs

DRUG STUDIES
STUDY RECRUITMENT

Study Recruitment
Number of Studies by Recruitment over Time (completion date)
Biologics
Drugs

Study Recruitment
Breakdown of Study Recruitment by Phase
Biologics
Drugs

DRUG STUDIES
STUDY DEMOGRAPHICS

Study Demographics: Gender
Number of studies by Gender of participants over Time (completion date)
BiologicsDrugs

Study Demographics: Gender
Breakdown of Study Participation by Gender by Phase
Biologics
Drugs

ARETE-ZOE, as a consultancy, provides solutions to complex problems in the
high stakes and high consequence environment of Global Pharmaceuticals,
including clinical research, healthcare informatics, and public
health. We blend established, Pharma sector methodologies, innovation, and
adaptations/transfers from other sectors to identify and resolve consequential
practices that pose risk and often result in avoidable patient casualty. However,
we are specifically, not a patient advocacy group but believe in optimizing
organizational effectiveness and that smart business is agile, competitive and
profitable, while intrinsically safe, secure, and resilient. We work within a global
context because transnational interests influence national circumstances and
choices at point of prescription.
ARETE-ZOE, provides full spectrum organizational and operational risk
management consultancy. Our published materials provide a glimpse of some
aspects of our services to demonstrate both knowledge and ongoing participation
within the Pharmaceutical Industry. Our analysis and consultancy includes all
channels of misuse, diversion, counterfeiting and illicit exploitation of
pharmaceuticals, medical devices, and precursor chemicals. Our advisement is to
manufactures, jurisdictional entities, insurers, legislators, litigators, patients, and
health care providers.
This scope also frequently segues into the nexus of crime and terrorism as
significant influencers that undermine sector integrity differentiated from other
criminal activity. Obviously, vulnerability assessment, information collection
management and intelligence production supporting decision-making for risk
reduction and interventions are routinely within the scope of our services as well
as design and implementation of operational control measures.

Trends in interventional clinical trials: Biologics

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Similar to Trends in interventional clinical trials: Biologics

Similar to Trends in interventional clinical trials: Biologics (20)

More from Arete-Zoe, LLC

More from Arete-Zoe, LLC (20)

Recently uploaded

Recently uploaded (20)

Trends in interventional clinical trials: Biologics